View:
United States securities and exchange commission logo
May 2, 2022
Mark Manfredi
Chief Executive Officer
Ikena Oncology, Inc.
645 Summer Street, Suite 101
Boston, MA 02210
Re: Ikena Oncology,
Inc.
Registration
Statement on Form S-3
Filed April 27,
2022
File No. 333-264517
Dear Dr. Manfredi:
This is to advise you that we have not reviewed and will not
review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 or Laura Crotty
at 202-551-7614 with
any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Stephanie Richards,
Esq.